Product Code: ETC11390565 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Antiemetics Drugs Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Antiemetics Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Antiemetics Drugs Market - Industry Life Cycle |
3.4 Greece Antiemetics Drugs Market - Porter's Five Forces |
3.5 Greece Antiemetics Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Greece Antiemetics Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Greece Antiemetics Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Greece Antiemetics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chemotherapy-induced nausea and vomiting (CINV) in cancer patients |
4.2.2 Growing awareness about the importance of managing post-operative nausea and vomiting (PONV) |
4.2.3 Rise in the geriatric population leading to higher incidences of nausea and vomiting disorders |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and commercialization |
4.3.2 Limited reimbursement policies for antiemetic drugs in Greece |
4.3.3 Competition from alternative therapies such as acupuncture and aromatherapy |
5 Greece Antiemetics Drugs Market Trends |
6 Greece Antiemetics Drugs Market, By Types |
6.1 Greece Antiemetics Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Greece Antiemetics Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Greece Antiemetics Drugs Market Revenues & Volume, By Serotonin Receptor Antagonists, 2021 - 2031F |
6.1.4 Greece Antiemetics Drugs Market Revenues & Volume, By Dopamine Antagonists, 2021 - 2031F |
6.1.5 Greece Antiemetics Drugs Market Revenues & Volume, By NK1 Receptor Antagonists, 2021 - 2031F |
6.2 Greece Antiemetics Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Greece Antiemetics Drugs Market Revenues & Volume, By Chemotherapy-Induced Nausea, 2021 - 2031F |
6.2.3 Greece Antiemetics Drugs Market Revenues & Volume, By Motion Sickness, 2021 - 2031F |
6.2.4 Greece Antiemetics Drugs Market Revenues & Volume, By Post-Surgical Nausea, 2021 - 2031F |
6.3 Greece Antiemetics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Greece Antiemetics Drugs Market Revenues & Volume, By Retail, 2021 - 2031F |
6.3.3 Greece Antiemetics Drugs Market Revenues & Volume, By Online, 2021 - 2031F |
6.3.4 Greece Antiemetics Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
7 Greece Antiemetics Drugs Market Import-Export Trade Statistics |
7.1 Greece Antiemetics Drugs Market Export to Major Countries |
7.2 Greece Antiemetics Drugs Market Imports from Major Countries |
8 Greece Antiemetics Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed antiemetic drug regimens |
8.2 Number of healthcare facilities offering antiemetic treatments |
8.3 Rate of adoption of new antiemetic drug formulations |
8.4 Average waiting time for patients to receive antiemetic drug prescriptions |
8.5 Patient satisfaction scores related to the effectiveness of antiemetic drugs |
9 Greece Antiemetics Drugs Market - Opportunity Assessment |
9.1 Greece Antiemetics Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Greece Antiemetics Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Greece Antiemetics Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Greece Antiemetics Drugs Market - Competitive Landscape |
10.1 Greece Antiemetics Drugs Market Revenue Share, By Companies, 2024 |
10.2 Greece Antiemetics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |